(Q51592230)

7 April 2018

title

HLA-A and breast cancer in West Peninsular Malaysia. (English)

1 reference

7 April 2018

0 references

5

1 reference

7 April 2018

author name string

Pooi Pooi Leong

1

1 reference

7 April 2018

Rohaizak Muhammad

2

1 reference

7 April 2018

Naqiyah Ibrahim

3

1 reference

7 April 2018

Soon Keng Cheong

4

1 reference

7 April 2018

publication date

13 January 2010

1 reference

7 April 2018

published in

Medical Oncology

1 reference

7 April 2018

volume

28

1 reference

7 April 2018

issue

1

1 reference

7 April 2018

page(s)

51-56

1 reference

7 April 2018

https://scigraph.springernature.com/pub.10.1007/s12032-009-9414-6

exact match

0 references

cites work

Does HLA type predispose some individuals to cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

The genetics of HLA-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

Brain glioma and human leukocyte antigens (HLA)--is there an association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

HLA system affects the age-at-onset in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

An update of the HLA genomic region, locus information and disease associations: 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

Breast cancer in Iran: a review of 903 case records

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

Anthropometry and breast cancer risk in Nigerian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

HLA-A2 expression, stage, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

Human leukocyte antigens as genetic markers in Greek patients with sporadic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

DNA methylation profiling of the human major histocompatibility complex: a pilot study for the human epigenome project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

DNA methylation density influences the stability of an epigenetic imprint and Dnmt3a/b-independent de novo methylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

HLA class II region genes and susceptibility to dermatitis herpetiformis: DPB1 and TAP2 associations are secondary to those of the DQ subregion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

Could TCR antagonism explain associations between MHC genes and disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

The Yin and Yang of HLA and KIR in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

Overview of breast cancer in Malaysian women: a problem with late diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-009-9414-6

Is there a relationship between HLA type and prognostic factors in breast cancer?

21 January 2018

1 reference

12 December 2020

Delay in breast cancer care: a study in Thai women

1 reference

12 December 2020

Lack of class I HLA expression in neuroblastoma is associated with high N-myc expression and hypomethylation due to loss of the MEMO-1 locus

1 reference

12 December 2020

Human Leukocyte Antigens and Multiple Basal Cell Carcinomas

1 reference

12 December 2020

Breast carcinoma in Pakistani women

1 reference

12 December 2020

Human leucocytic antigens (HLA) in breast cancer

1 reference

12 December 2020

The regulatory complex of HLA class I promoters exhibits locus-specific conservation with limited allelic variation.

1 reference

12 December 2020

Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan.

1 reference

12 December 2020

Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses

1 reference

12 December 2020

Homozygosity in the major histocompatibility complex region influences natural killer cell activity in man

1 reference

12 December 2020

HLA-A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer

1 reference

12 December 2020

[Expression of the major histocompability complex HLA-A2 gene in ovarian cancer]

1 reference

12 December 2020

HLA-ABC antigens in supraglottic cancer patients and their relationship with incidence and survival

1 reference

12 December 2020

Relationship of breast cancer and HLA in Japanese females

1 reference

12 December 2020

Association of HLA phenotype with response to active specific immunotherapy of melanoma

1 reference

12 December 2020

Human leukocyte antigen class I and II haplotypes and risk of cervical cancer

1 reference

12 December 2020

HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK

1 reference

12 December 2020

Tumor biology and prognosis in black breast cancer patients: a review

1 reference

12 December 2020

Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.

1 reference

12 December 2020

10.1007/S12032-009-9414-6

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018